in addition with cmuc patients do not have to pay upfront which is the common rule in france lowincome patients and recipients of social benefits have reduced copayments on pharmaceuticals the government subsidises socalled verylowcostaccess vlca practices which typically serve disadvantaged areas under the condition that they forgo revenue from patient fees